乙肝和丙肝2009展望

帅庭

文章导读：HBV-and HCV-related chronic hepatitis are the main causes of cirrhosis and hepatocellular carcinoma (HCC) that are responsible for a high rate of morbidity and mortality.

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are among the most frequent viral infections in humans, and represent a major global public health problem. HBV-and HCV-related chronic hepatitis are the main causes of cirrhosis and hepatocellular carcinoma (HCC) that are responsible for a high rate of morbidity and mortality. End-stage HBV-and HCV-related liver disease and HCC are the main causes of liver transplantation. In the last few years, knowledge of the epidemiology and the natural history of HBV and HCV infection has markedly improved. Furthermore, considerable progress has been made in the efficacy of therapy. New drugs and new therapeutic strategies that are currently under evaluation could further improve the efficacy of therapy in the near future.
更多精彩内容请点击：http://aphc.ihepa.com/15-160-1958.html

jiahuida

说中国话吧@@@

jiahuida

没看懂！！

红阳渡口

期待国语

waaan

英文好的翻译一下吧。

xdygu4

看不懂，俺文化水平比较低............

干扰中

乙型肝炎病毒和丙型肝炎病毒相关慢性肝炎的主要原因是肝硬化和肝细胞癌（ HCC ）是负责率高，发病率和死亡率。

乙型肝炎病毒（ HBV ）和丙型肝炎病毒（ HCV ）感染是最常见的病毒感染人类，并代表了全球主要的公共卫生问题。乙型肝炎病毒和丙型肝炎病毒相关慢性肝炎的主要原因是肝硬化和肝细胞癌（ HCC ）是负责率高，发病率和死亡率。终末期乙型肝炎病毒和丙型肝炎病毒相关肝病和肝癌的主要原因是肝移植。在过去几年中，知识的流行病学和自然史的HBV和HCV感染的显着改善。此外，已取得相当进展的疗效。新药物和新的治疗战略，目前正在评价可进一步提高疗效在不久的将来。

拜田八放斋

都是空话～～年年都是这么几句～～～